Crying-induced bronchospasm in childhood asthma: response to nebulized metaproterenol 5% and sodium cromoglycate 1%

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology

Background:

• Crying-induced bronchospasm is a challenging condition in young asthmatic children.
• Existing oral therapies like theophylline and metaproterenol may not always be effective.

Purpose of the Study:

• To evaluate the efficacy of nebulized metaproterenol and sodium cromoglycate in treating crying-induced bronchospasm.
• To assess the impact of this treatment on both crying and non-crying-related asthma symptoms.

Main Methods:

• An 8-week uncontrolled study involving five asthmatic children aged 2 to 5 years.
• Patients received nebulized metaproterenol 5% and sodium cromoglycate 1%.
• Treatment was administered for persistent bronchospasm refractory to oral medications.

Main Results:

• All five patients experienced a reduction in both crying and non-crying-related asthma symptoms.
• Three out of five patients showed a decrease in crying behavior.
• The combination therapy demonstrated positive outcomes in managing refractory asthma.

Conclusions:

• Nebulized metaproterenol and sodium cromoglycate show potential efficacy in treating crying-induced bronchospasm.
• This treatment approach may be a viable option for children with asthma refractory to oral bronchodilators.